T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Murphy USA
MUSA
$10.2B
| $86.9M | 0.01% |
243,701
+1,634
| +0.7% | +$592K |
|
|
AKRO
577
DELISTED
Akero Therapeutics
AKRO
| $85.8M | 0.01% |
3,675,924
-134,270
| -4% | -$2.65M |
|
578
Manhattan Associates
MANH
$11.4B
| $85.6M | 0.01% |
397,666
+28,083
| +8% | +$5.94M |
|
579
Builders FirstSource
BLDR
$7.96B
| $85.6M | 0.01% |
512,866
+60,916
| +13% | +$8.1M |
|
|
RAPT
580
DELISTED
RAPT Therapeutics
RAPT
| $84.8M | 0.01% |
426,694
-15,786
| -4% | -$1.95M |
|
581
Parker-Hannifin
PH
$133B
| $83.8M | 0.01% |
181,881
+7,697
| +4% | +$3.2M |
|
582
Ecolab
ECL
$77.3B
| $82.9M | 0.01% |
418,104
+2,754
| +0.7% | +$495K |
|
583
Omnicom Group
OMC
$23.8B
| $82.8M | 0.01% |
957,276
-35,619
| -4% | -$2.81M |
|
584
Ameriprise Financial
AMP
$49.9B
| $82.7M | 0.01% |
217,635
-1,046
| -0.5% | -$359K |
|
|
NUVL
585
DELISTED
Nuvalent
NUVL
| $81.4M | 0.01% |
1,106,382
+299,446
| +37% | +$18.5M |
|
586
Clean Harbors
CLH
$16.8B
| $81.1M | 0.01% |
464,806
-43,724
| -9% | -$7.18M |
|
587
Scholastic
SCHL
$785M
| $80.8M | 0.01% |
2,143,718
-1,296,973
| -38% | -$49.6M |
|
588
Texas Roadhouse
TXRH
$13.9B
| $80.6M | 0.01% |
659,423
-7,496
| -1% | -$801K |
|
589
Mettler-Toledo International
MTD
$28.5B
| $79M | 0.01% |
65,146
-49,899
| -43% | -$54M |
|
590
Rocket Pharmaceuticals
RCKT
$371M
| $78.8M | 0.01% |
2,629,074
-8,877
| -0.3% | -$196K |
|
|
ANSS
591
DELISTED
Ansys
ANSS
| $78.7M | 0.01% |
216,884
-24,375
| -10% | -$7.22M |
|
592
Qualys
QLYS
$6.54B
| $78.7M | 0.01% |
400,758
-6,301
| -2% | -$1.1M |
|
593
Arch Capital
ACGL
$33.2B
| $77.6M | 0.01% |
1,045,440
-70,158
| -6% | -$5.73M |
|
594
Medpace
MEDP
$16.4B
| $77.5M | 0.01% |
252,878
-13,619
| -5% | -$3.68M |
|
595
Warrior Met Coal
HCC
$5.08B
| $77.4M | 0.01% |
1,269,510
+23,416
| +2% | +$1.24M |
|
596
Ivanhoe Electric
IE
$1.66B
| $77.2M | 0.01% |
7,657,119
-804,667
| -10% | -$8.51M |
|
597
Casella Waste Systems
CWST
$5.79B
| $76.7M | 0.01% |
897,564
-35,012
| -4% | -$2.81M |
|
598
Palantir
PLTR
$421B
| $76.6M | 0.01% |
4,464,040
+3,310,179
| +287% | +$59M |
|
|
CHX
599
DELISTED
ChampionX
CHX
| $76.4M | 0.01% |
2,616,619
-624,590
| -19% | -$19.3M |
|
600
On Holding
ONON
$10.3B
| $74.8M | 0.01% |
2,773,197
+1,235,314
| +80% | +$33.7M |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.